Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 20 | 300 | 100 | 4 | 40 |
| Receivables | 660 | 110 | 50 | 10 | 20 |
| Inventories | N/A | N/A | N/A | 20 | N/A |
| Other current assets | -240 | 610 | 330 | 16 | 10 |
| TOTAL | $440 | $1,020 | $480 | $50 | $70 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $10 | $10 | $10 | $10 | $10 |
| Total Assets | $1,000 | $1,080 | $530 | $80 | $100 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $2,560 | $2,880 | $1,810 | $1,280 | $1,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,580 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $2,580 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $5,140 | $4,380 | $3,310 | $2,780 | $2,560 |
| Shareholders' Equity | |||||
| Common Shares | 190 | 190 | 180 | 180 | 180 |
| Retained earnings | -22,970 | -22,040 | -21,500 | -21,330 | -21,080 |
| Other shareholders' equity | 10 | 0 | 20 | 20 | 10 |
| TOTAL | $-4,540 | $-3,790 | $-3,260 | $-3,170 | $-2,920 |
| Total Liabilities And Equity | $600 | $590 | $50 | $-390 | $-360 |